As part of London Bio-Innovation Week, join UKHSA and Canary Wharf Life Sciences for insight and networking from leading diagnostics experts, including BIVDA’s AMR expert Dr Jayne Ellis.
The Future of Diagnostics with UKHSA and Canary Wharf Life Sciences
UKHSA have teamed up with Canary Wharf Life Sciences to deliver this One Nucleus/BioInnovation Week Fringe event on diagnostics.
The COVID-19 pandemic proved to us how vital it was to have the right diagnostics in place to identify and control the spread of the disease. The UKHSA’s mission is to prepare for, prevent and respond to health threats, save lives and protect livelihoods. In order to do this, it is crucial that they have the right diagnostics in place for the future.
Come and learn more about UKHSA and how they are working with partners to future proof diagnostics in preparation for the next health threat and how new regulations might impact your work.
Agenda as follows:
5.30- Registration, tea & coffee
5.45– Welcome
5.50- Introduction to Canary Wharf Life Sciences , Mairi Dillon (Associate Director, Science Ecosystem)
6.05- Introduction to UKHSA, Mark Wareing (Head of Business Development)
6.20- Diagnostics at UKHSA, Richard Vipond (Deputy Director, Diagnostics and Pathogen Characterisation)
6.40- Panel Discussion: The Future of Diagnostics
- Emily Adams, Chief Global Health Officer, Global Access DX & University of Oxford
- Jayne Ellis, Scientific Advisor, British In Vitro Diagnostics Association (BIVDA) & JEMMDx
- Simon Parker, Portfolio Lead Core Lab, Roche
- Kerrie Davies MBE, Consultant Clinical Scientist/Head of HCAI Group Laboratory, Leeds Teaching Hospitals NHS Trust
7.40- Drinks, light bites & Networking
8.45- Close
You can register here.
